Marinus Pharmaceuticals investor relations material
Listen to the latest call from Marinus Pharmaceuticals
Marinus Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing and commercializing therapeutics to treat epilepsy with a focus on rare and orphan seizures, as well as neuropsychiatric disorders in the United States.
Ticker
MRNSCountry
US